Patents
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
06/2003
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/19/2003US20030114455 Sexual disorders
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/03/2003US6573263 For improving perception, concentration power, learning power and/ or memory power
05/2003
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/28/2003EP1313480A2 Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/22/2003WO2003042192A1 Preparation of 3-amino-1,2,4-benzotriazine dioxide
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/21/2003EP1311492A1 Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/02/2003EP1305027A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
04/2003
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/10/2003US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide
04/10/2003US20030069140 Herbicides
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/08/2003CA2001903C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
04/02/2003CN1407893A Triazinone compounds for treating diseases resulting from infretation with parasitic protozoans
04/02/2003CN1104432C Pyrrole triazines and pyrimidine compound
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/2003
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1286968A2 Substituted iminoazines
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
02/2003
02/27/2003WO2002067675A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/20/2003US20030036544 Pesticidal triazine-derivatives
02/18/2003WO2002016329A1 Novel phenylalanine derivatives
02/18/2003US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/13/2003WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
02/13/2003CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
02/11/2003US6518269 Cancer treatment
02/06/2003WO2002056682A3 Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/05/2003EP1280764A2 Inhibitors of histone deacetylase
02/05/2003EP1082121A4 Hiv integrase inhibitors
02/05/2003EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS
02/05/2003CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids
01/2003
01/30/2003WO2003008393A1 Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
01/30/2003WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies
01/30/2003US20030023086 For therapy of thrombosis in humans and other mammals
01/29/2003EP0889884B1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
01/29/2003CN1100036C Prourokinase and urokinase affinity ligand and its usage
01/23/2003US20030018030 Antiepileptic agents
01/22/2003EP0646115B1 Heterocyclic-cyclic amine derivatives
01/21/2003US6509399 Non-yellowing part-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers
01/21/2003US6509354 3-arylphenyl sulfide derivative and insecticide and miticide
01/16/2003US20030013713 Compounds as PDE IV and TNF-inhibitors
01/14/2003US6506517 Surface modified carbonaceous materials
01/09/2003WO2002009716A3 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
01/09/2003US20030008842 Formulations of adenosine a1 agonists
01/09/2003US20030007941 Method of treating hair loss using thyromimetic compounds
01/08/2003CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/08/2003CN1389203A Method for treating hair-dropping using thyromimetic compound
01/03/2003WO2002009715A3 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer
01/02/2003EP1268408A1 Arthropodicidal carboxanilides
01/01/2003CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds
12/2002
12/31/2002US6500847 Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids
12/26/2002US20020198377 For improving perception, concentration power, learning power and/ or memory power
12/24/2002US6498158 Il-5 inhibiting 6-azauracil derivatives
12/19/2002US20020193596 Inhibitors of protein isoprenyl transferases
12/18/2002EP1265869A2 N-halamine vinyl compounds and their polymeric biocides
12/18/2002EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/12/2002WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002WO2002098879A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/11/2002EP1264820A1 Novel amide compounds
12/04/2002EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
11/2002
11/21/2002WO2002068398A9 New crystal forms of lamotrigine and processes for their preparations
11/07/2002WO2002088084A1 Heterocyclic compound derivatives and medicines
11/06/2002EP1254122A2 Novel 3-substituted 1,2,4-benzotriazines, a method for their production and the use thereof
11/04/2002WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/29/2002US6472529 Viricides
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 30